


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
RNA
Avidity Biosciences
$71.30
Strengths

Upgraded on attractively valued
RNA Price Performance
$70.82 (+0.68%)
$41.44 (+72.06%)
$34.02 (+109.58%)
$31.64 (+125.35%)
RNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

RNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
RNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
RNA Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is RNA current stock price?
What are RNA stock strengths?
What is RNA Risk Level?
What is RNA market cap and volume?
What is RNA current Stock IQ?
Should I buy RNA stock right now?
Is RNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for RNA?
What does a 'Strong Sell' rating mean for RNA?
What factors influence RNA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
RNA
Avidity Biosciences
Current Price
$71.30
Stock Insights
Strengths

Upgraded on attractively valued

RNA Price Performance
$70.82 (+0.68%)
$41.44 (+72.06%)
$34.02 (+109.58%)
$31.64 (+125.35%)
RNA Analysts Opinion
RNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
RNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
RNA Street Sentiment is extremely bullish and have negative views on the near-term outlook
RNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
RNA Stock IQ
RNA Latest Analysis
Avidity Biosciences Inc. (RNA): A Case Theory . We came across a ish thesis on Avidity Biosciences Inc. on BiotechBonanzas Substack by AnotherBio. In this article we will summarize the s thesis on RNA. Avidity Biosciences Inc.’.s share was trading at $71.54 as of December 2nd. Novartis is acquiring Avidity RNA a pre-Phase 3 biotech company in a straightforward deal with no overlap between the two businesses. The [….]
Thu Dec 4, 2025
Heres How Much $100 Invested In Avidity Biosciences 5 Years Ago Would Be Worth Today. Avidity Biosciences (NASDAQ:RNA) has outperformed the market over the past 5 years by 6.63% on an annualized basis producing an average annual return of 19.41%. Currently Avidity Biosciences has a market capitalization of $10.62 billion.
Wed Nov 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.